Progressive multifocal leukoencephalopathy medical therapy: Difference between revisions
(Created page with "{{Progressive multifocal leukoencephalopathy}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{Gastroenterology}} {{Viral diseases}} [[de:Progressive multifokale Leukenz...") |
No edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
There is no known cure. In some cases, the disease slows or stops if the patient's [[immune system]] improves; some AIDS patients with PML have been able to survive for several years, with the advent of [[antiretroviral drug|highly active antiretroviral therapy]](HAART). | |||
AIDS patients who start HAART after being diagnosed with PML tend to have a slightly longer survival time than patients who were already on HAART and then develop PML (Wyen et al., 2004). A rare complication of effective HAART is [[immune reconstitution inflammatory syndrome]] (IRIS), in which increased immune system activity actually increases the damage caused by the infection; though IRIS is often manageable with other types of infections, it is extremely dangerous if it occurs in PML (Vendrely et al., 2005). | |||
Other antiviral agents that have been studied as possible treatments for PML include [[cidofovir]] and [[interleukin-2]], but this research is still preliminary. | |||
Cytarabine (A.K.A. ARA-C), a chemotherapy drug approved by the US FDA to treat certain cancers, has been prescribed on an experimental basis for a small number of non-AIDS PML patients. Cytarabine is reported to have stabilized the neurological condition of a minority of these patients (Aksamit, 2001). One patient regained some cognitive function lost by PML (Langer-Gould et al., 2005). | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 23:30, 7 February 2012
|
Progressive multifocal leukoencephalopathy Microchapters |
|
Differentiating Progressive multifocal leukoencephalopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Progressive multifocal leukoencephalopathy medical therapy On the Web |
|
American Roentgen Ray Society Images of Progressive multifocal leukoencephalopathy medical therapy |
|
FDA on Progressive multifocal leukoencephalopathy medical therapy |
|
CDC on Progressive multifocal leukoencephalopathy medical therapy |
|
Progressive multifocal leukoencephalopathy medical therapy in the news |
|
Blogs on Progressive multifocal leukoencephalopathy medical therapy |
|
Risk calculators and risk factors for Progressive multifocal leukoencephalopathy medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
There is no known cure. In some cases, the disease slows or stops if the patient's immune system improves; some AIDS patients with PML have been able to survive for several years, with the advent of highly active antiretroviral therapy(HAART).
AIDS patients who start HAART after being diagnosed with PML tend to have a slightly longer survival time than patients who were already on HAART and then develop PML (Wyen et al., 2004). A rare complication of effective HAART is immune reconstitution inflammatory syndrome (IRIS), in which increased immune system activity actually increases the damage caused by the infection; though IRIS is often manageable with other types of infections, it is extremely dangerous if it occurs in PML (Vendrely et al., 2005).
Other antiviral agents that have been studied as possible treatments for PML include cidofovir and interleukin-2, but this research is still preliminary.
Cytarabine (A.K.A. ARA-C), a chemotherapy drug approved by the US FDA to treat certain cancers, has been prescribed on an experimental basis for a small number of non-AIDS PML patients. Cytarabine is reported to have stabilized the neurological condition of a minority of these patients (Aksamit, 2001). One patient regained some cognitive function lost by PML (Langer-Gould et al., 2005).
References
Template:Gastroenterology Template:Viral diseases de:Progressive multifokale Leukenzephalopathie nl:Progressieve multifocale leukoencefalopathie